The FDA shortage designation for semaglutide and tirzepatide has been resolved, and the FDA has proposed excluding these drugs from the 503B bulks list
For weight loss only, they are available privately through online and in-person weight loss clinics, as well as NHS weight-loss services
Available online: 159.Gupta S.C., Patchva S., Aggarwal B.B
Who Is a Candidate for GLP-1 Treatment
For 76% of women, the main reason for starting GLP-1 medication is to improve physical appearance, while 72% of men cite health concerns as their primary motivation
Surg Obes Relat Dis 18(3):373383 Beavers KM, Greene KA, Yu EW (2020) Management of endocrine disease: bone complications of bariatric surgery: updates on sleeve gastrectomy, fractures, and interventions